Our interventional cardiologists have been performing structural heart repairs for a patent foramen ovale (PFO) or an atrial septal defect (ASD) since 2005, as part of the structural heart disease program at TriHealth’s Good Samaritan Hospital.
Percutaneous, or catheter-based, closure of PFO (in patients with a cryptogenic cerebrovascular event) has emerged as an alternative to medical treatment due to studies linking PFO to these events. With an average of 14 cases annually, we have a 100 percent success rate with a very low incidence of procedure or device-related complications, reinforcing our long-trusted commitment to heart care excellence.
Benefits of Catheter-Based Structural Heart Repairs
Percutaneous or catheter-based, closure of an atrial septal defect (ASD) has replaced the surgical approach as the standard treatment to close communications between the left and right atria, with the surgical approach being reserved for defects that are unsuitable for the transcatheter approach. With percutaneous closure, patients receive relief from symptoms of reduced exercise tolerance, shortness of breath, palpitations, atrial arrhythmias and pulmonary vascular disease.